Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2009-04-09 | Dr. Abraham Ludomirski 131,500 148,200 279,700 Member of the Nominating and Corporate Governance Committee, Compensation Committee, and Strategic Affairs Committee |
2010-04-27 | Dr. Abraham Ludomirski is the founder and, for more than the past five years, managing director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. He is also the Chairman of the Board of Sightline Technologies Ltd., an Israeli high-tech company specializing in miniature electronics and optical and video systems, and serves on the board of directors of Medison, Trig Medical, Deep Breeze and Canfite. Dr. Ludomirski earned his M.D. at the Sackler Tel-Aviv University Medical School, specializing in OBGYN and completed his fellowship at the University of Pennsylvania in maternal fetal medicine. In addition to his general familiarity with corporate affairs and governance, Dr. Ludomirski’s work in the high-tech venture capital and medical fields gives him a valuable perspective on investment in innovative technologies. |
2011-04-12 | Dr. Abraham Ludomirski is the founder and, for more than the past five years, managing director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. |
2012-04-05 | Dr. Abraham Ludomirski is the founder and, for more than the past five years, managing director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. He is also the Chairman of the Board of Sightline Technologies Ltd., an Israeli high-tech company specializing in miniature electronics and optical and video systems, and serves on the board of directors of Medison, Trig Medical, Deep Breeze and Canfite. Dr. Ludomirski earned his M.D. at the Sackler Tel-Aviv University Medical School, specializing in OBGYN and completed his fellowship at the University of Pennsylvania in maternal fetal medicine. In addition to his general familiarity with corporate affairs and governance, Dr. Ludomirski’s work in the high-tech venture capital and medical fields gives him a valuable perspective on investment in innovative technologies. |
2013-04-05 | Dr. Abraham Ludomirski is the founder and, for more than the past five years, managing director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. |
2014-04-04 | Dr. Abraham Ludomirski is the founder and, for more than the past five years, managing director of Vitalife Fund ... The following table provides information with respect to the compensation paid or provided to the Company's non-employee directors during 2013: ... Dr. Abraham Ludomirski $182,500 ... The current chairman of the Committee is Dr. Abraham Ludomirski. |
2015-04-02 | The Nominating and Corporate Governance Committee, with the help of counsel, has reviewed the applicable legal standards for Board and committee member independence, the Company's standards of independence and applied the criteria to determine "audit committee financial expert status". The Committee has also reviewed a summary of the answers to annual questionnaires completed by each director. On the basis of this review the Committee has communicated its findings to the full Board and the Board has affirmatively concluded that Frank Dieter Maier, Dr. Abraham Ludomirski, Wayne M. Rogers, Ronald Ruzic, Timothy Talbert, and Thomas Wertheimer qualify as independent directors. Each of the Audit Committee, the Nominating and Corporate Governance Committee, and the Compensation Committee of the Board is composed entirely of independent directors. The following table provides information with respect to the compensation paid or provided to the Company's non-employee directors during 2014. |
2017-03-31 | Dr. Abraham Ludomirski is the founder and managing director of Vitalife Fund...The Board has affirmatively concluded that Dr. Abraham Ludomirski qualifies as an independent director...The following table summarizes the composition of these Committees as of March 27, 2017...Dr. Abraham Ludomirski: Nominating and Corporate Governance Committee (Chairman), Compensation Committee (Member)...Director compensation table: Dr. Abraham Ludomirski total $184,800. |
2018-03-23 | The Nominating and Corporate Governance Committee, with the help of counsel, has reviewed the applicable legal standards for Board and committee member independence, the Company's standards of independence and applied the criteria to determine "audit committee financial expert status". The Committee has also reviewed a summary of the answers to annual questionnaires completed by each director. On the basis of this review the Committee has communicated its findings to the full Board and the Board has affirmatively concluded that Frank Dieter Maier, Dr. Abraham Ludomirski, Ronald Ruzic, Timothy Talbert, Thomas Wertheimer, and Raanan Zilberman qualify as independent directors. Each of the Audit Committee, the Nominating and Corporate Governance Committee, and the Compensation Committee of the Board is composed entirely of independent directors. The following table summarizes the composition of these Committees as of March 19, 2018: Nominating and Corporate Governance Committee (Chairman), Compensation Committee (Member). Director Compensation: Dr. Abraham Ludomirski receives $80,000 fees earned and paid in cash and stock awards of $158,071 for a total of $238,071. |
2019-03-22 | Dr. Abraham Ludomirski is the founder and, for more than the past five years, managing director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. He is also the Chairman of the Board of POCARED Diagnostics, Ltd., an Israeli high-tech company specializing in miniature electronics and optical and video systems, and serves on the board of directors of Recro Pharma, Inc., Sensible Medical Innovations Ltd., Trig Medical, ENDOSPAN Ltd., and DIR Technologies. Dr. Ludomirski earned his M.D. at the Sackler Tel-Aviv University Medical School, specializing in OBGYN and completed his fellowship at the University of Pennsylvania in maternal fetal medicine. In addition to his general familiarity with corporate affairs and governance, Dr. Ludomirski's work in the high-tech venture capital and medical fields gives him a valuable perspective on investment in innovative technologies. |
2020-03-25 | Dr. Abraham Ludomirski, 68, Independent Director, Chair of Nominating and Corporate Governance Committee, Member of Compensation Committee, Total compensation: $233,464 |
2021-04-05 | Dr. Abraham Ludomirski is the founder and, for more than the past five years, managing director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. He is also the Chairman of the Board of POCARED Diagnostics, Ltd., an Israeli high-tech company specializing in miniature electronics and optical and video systems, and serves on the board of directors of Sensible Medical Innovations Ltd., Trig Medical, ENDOSPAN Ltd., and DIR Technologies. He previously served on the board of Recro Pharma, Inc. Dr. Ludomirski earned his M.D. at the Sackler Tel-Aviv University Medical School, specializing in OBGYN and completed his fellowship at the University of Pennsylvania in maternal fetal medicine. In addition to his general familiarity with corporate affairs and governance, Dr. Ludomirski's work in the high-tech venture capital and medical fields gives him a valuable perspective on investment in innovative technologies. |
2022-04-04 | Dr. Abraham Ludomirski is the founder and, for more than the past five years, managing director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. He serves on the board of directors of POCARED Diagnostics, Ltd., Newpace Ltd., Sensible Medical Innovations Ltd., and Trig Medical, as well as serving as the Chairman of the Board of ENDOSPAN Ltd. and Endoran. He also serves as CEO of Illumigyn. He previously served on the board of Recro Pharma, Inc. and DIR Technologies. Dr. Ludomirski earned his M.D. at the Sackler Tel-Aviv University Medical School, specializing in OBGYN and completed his fellowship at the University of Pennsylvania in maternal fetal medicine. In addition to his general familiarity with corporate affairs and governance, Dr. Ludomirski's work in the high-tech venture capital and medical fields gives him a valuable perspective on investment in innovative technologies. |
2023-04-04 | Dr. Abraham Ludomirski 71 2003 2026 Founder and Managing Director of Vitalife Fund Leadership, Global ✓ C M |
2024-04-01 | Dr. Abraham Ludomirski, 72, Founder and Managing Director of Vitalife Fund, Chair of Nominating and Corporate Governance Committee, Member of Compensation Committee, Total Compensation $264,988. |
2025-03-31 | Founder and Managing Director of Vitalife Fund, a venture capital company specializing in high-tech electronic medical devices. |
Data sourced from SEC filings. Last updated: 2025-08-30